How I treat infant leukemia

Patrick Brown, Rob Pieters, Andrea Biondi

Onderzoeksoutput: Bijdrage aan tijdschriftArtikelpeer review

51 Citaten (Scopus)

Samenvatting

Leukemia in infants is rare but generates tremendous interest due to its aggressive clinical presentation in a uniquely vulnerable host, its poor response to current therapies, and its fascinating biology. Increasingly, these biological insights are pointing the way toward novel therapeutic approaches. Using representative clinical case presentations, we review the key clinical, pathologic, and epidemiologic features of infant leukemia, including the high frequency of KMT2A gene rearrangements. We describe the current approach to risk-stratified treatment of infant leukemia in the major international cooperative groups. We highlight recent discoveries that elucidate the molecular biology of infant leukemia and suggest novel targeted therapeutic strategies, including modulation of aberrant epigenetic programs, inhibition of signaling pathways, and immunotherapeutics.

collaboration to translate these discoveries into improved outcomes.

Originele taal-2Engels
Pagina's (van-tot)205-214
Aantal pagina's10
TijdschriftBlood
Volume133
Nummer van het tijdschrift3
DOI's
StatusGepubliceerd - 17 jan. 2019

Vingerafdruk

Duik in de onderzoeksthema's van 'How I treat infant leukemia'. Samen vormen ze een unieke vingerafdruk.

Citeer dit